For Immediate Release: February 22, 2022 Media Contact: Maria Landron | [email protected] The STATUS List is the most definitive accounting of important and impactful individuals in health, medicine, and science With the premiere of “Augmented,” a bevy of notable hires, and now the STATUS List, STAT continues to expand its reach and influence BOSTON — STAT,…
In the latest edition of STAT Health Tech: how to train your AI to predict bad outcomes, the ripple effects of privacy laws, and digital health's notable leaders.
Wojcicki co-founded 23andMe 16 years ago, and although the company is best known for its low-cost consumer genetic testing service, it works on a variety of health care and biotechnology fronts. A test for prostate cancer risk won FDA clearance this January. 23andMe has recently launched, in partnership with GSK, a clinical trial for an…
An experimental antiviral pill developed by Pfizer reduced the risk of death and hospitalization by 89% in patients who were newly diagnosed with Covid-19.
“What are the chances 23andMe is going to be one of the last-standing, dominant players in telemedicine? I would say the chances are very low.”
In the latest edition of STAT Health Tech: Noom steps into mental health, Big Health inks a big deal, & a new virtual care startup on the block.
Marley Medical launched Thursday with a promise to treat chronic conditions with an array of remote services and a team-based approach.
Lyra, the mental health startup that’s piled up a $4.6 billion valuation, announced a new slate of offerings tackling serious mental health conditions.
Apple is gearing up to release a new metric called Walking Steadiness aimed at preventing falls in older people, but so far, the company has only shared a narrow glimpse of studies underpinning the tool.
This year’s Summit will feature expert voices from the FDA, leading pharmaceutical companies and other industry stakeholders BOSTON, MA – STAT, the nation’s must-read health, science, and medicine publication, recently announced that its inaugural 2021 STAT Breakthrough Science Summit will take place July 13-14. After a year that forced to innovation at unprecedented speed, the…
“Savvy consumers really want a better system than what we have,” said Lucia Savage, chief privacy officer of Omada Health.
The data-syncing platform lets patients combine health information from electronic health records, wearables, and DNA sequencing platforms.
View Highlights About Come here for the cutting edge Technologies and procedures that would have been science fiction are now the reality of medicine. Our 2021 STAT Breakthrough Science Summit took attendees inside these innovations, examining how they're being developed, adopted, and paid for. We also explored the breakthroughs that haven't yet hit the market,…
When will 23andMe turn a profit? And how central will drug development become to its business?
The Pajama Interview: A conversation with 23andMe's Anne Wojcicki and Virgin's Richard Branson.
"In my opinion, there's no better way to invest your money than in health care," said Richard Branson.
“Diversity’s literally in our DNA, because there’s no way I’m doing a study that’s just European folks because I want it to apply to everybody,” TruGenomix's Tshaka Cunningham said.
23andMe CEO Anne Wojcicki wants customers to “feel proud” if a drug developed with their data reaches the market, but the company still has to figure out how to ensure they have access to these medicines.
Today marks a milestone for us at STAT. We published the 2,000th First Opinion, our forum for perspectives and personal stories about health, medicine, and science.
"Frankly, we were actually quite surprised that sales rebounded quite a bit from March," @23andMe CEO Anne Wojcicki told STAT.
Hospital CEOs and academic leaders at the level of deans and presidents should devote their full attention to their day jobs and defer positions on the boards of for-profit companies to the post-leadership phase of their careers.
The effort to validate drugs with 23andMe's vast genetic database is “exceeding, I think, everyone’s expectations,” said Hal Barron, GlaxoSmithKline’s chief scientific officer.
Nov 16-19Online#statsummit About The 2020 STAT Summit: What’s next? The coronavirus pandemic has reset our expectations of what is possible. New medicines and vaccines are being developed at a previously unimaginable pace. Telemedicine has replaced the doctor’s office. Now, we’re starting to figure out how the world has been reshaped in the wake of Covid-19,…
23andMe says it’s ‘part of the problem’ on racial inequity. STAT asked geneticists and health disparities experts what the company and its competitors can do about it.
About The STAT Health Tech Summit is complete And that’s a wrap! Thanks to all who helped make this first virtual Summit so special. If you weren’t able to join us, you can read all of the event coverage. Where health tech meets biotech Breakthroughs in health and medicine are not just biological — they’re…
In the latest sign of a slump in consumer genetic testing, 23andMe is laying off 14% of its workforce amid falling sales of its DNA spit kits.
The new episode of our "Readout LOUD" podcast is here! Listen now:
Can artificial intelligence “democratize” the use of the heart ultrasound?
Dog owners may want genetic screening for their dogs, but several veterinarians and scientists say companies too often provide misleading results.
